The European Commission concluded exploratory talks on Tuesday with European biotechnology company Valneva with a view to purchasing up to 60 million doses of its COVID-19 vaccine once it proves to be safe and effective.
Fuente: Youtube
The European Commission concluded exploratory talks on Tuesday with European biotechnology company Valneva with a view to purchasing up to 60 million doses of its COVID-19 vaccine once it proves to be safe and effective.
Fuente: Youtube
